期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

帕利哌酮与阿立哌唑治疗精神分裂症的疗效观察 被引量：9

下载PDF
导出
摘要 目的比较帕利哌酮与阿立哌唑治疗精神分裂症的疗效及安全性。方法 70例精神分裂症患者随机分为帕利哌酮组和阿立哌唑组,每组各35例,疗程均为8周,评定临床疗效及不良反应。结果帕利哌酮组疗效优于阿立哌唑组(P<0.05),且帕利哌酮起效较阿立哌唑为快,二者不良反应均轻微。结论帕利哌酮与阿立哌唑均是安全有效的抗精神病药物,但帕利哌酮总体疗效更好,起效更快。
作者 林文
机构地区 福州神经精神病防治院
出处 《中国实用神经疾病杂志》 2012年第24期67-69,共3页 Chinese Journal of Practical Nervous Diseases
关键词 帕利哌酮 阿立哌唑 非典型抗精神病药 精神分裂症
分类号 R749.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献12

  • 1刘向阳,李云,马衡.齐拉西酮与奋乃静治疗急性精神分裂症对照研究[J].中国实用神经疾病杂志,2012,15(4):28-29. 被引量：8
  • 2庞月萍.康复指导对慢性精神分裂症患者社会生活适应能力的影响[J].中国实用神经疾病杂志,2012,15(1):50-52. 被引量：1
  • 3Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a recta- analysis[J]. Lancet,2009,373 (9657) :31-41.
  • 4Chwieduk CM, Keating GM. Paliperidone extended release: a review of its use in the management of schizophrenia [J]. Drugs,2010,70(10) :1 295-1 317.
  • 5Melnik T,Soares BG,Puga ME, et al. Efficacy and safety of a typical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsy- chotie drugs for treating refractory schizophrenia: overview of systematic reviews[J]. Sao Paulo Med J, 2010, 128 (3) : 141- 166.
  • 6中华医学会精神分会编.CCMD-3中国精神障碍分类与诊断标准[M].3版.济南:山东科学技术出版社,2001:86-87.
  • 7Kay SR, Fiszbein A, Opler LA. The positive and negative syn- drome scale (PANSS) for sehizophrenia[J]. Schizophr Bull, 1987,13(2) :261-276.
  • 8Lieberman JA, Stroup TS, McEvoy JP, et ah Effectiveness of antipsyehotie drugs in patients with chronic schizophrenia [J]. N Engl J Meal,2005,353 (12):1 209-1 223.
  • 9Citrome L. Paliperidone palmitate-review of the efficacy, safety and cost of a new second-generation depot antipsychotic medi-cation[J]. Int J Clin Pract,2010,64(2) :216 -239.
  • 10Jones MP, Nicholl D, Trakas K. Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schiz- ophrenia[J]. Int J Clin Pharmacol Ther, 2010, 48 (6) :383- 399.

二级参考文献7

共引文献9

同被引文献103

  • 1司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量：95
  • 2Okumura Y, Ito H,Kobayashi M, et al. Prevalence of diabetes and antipsychotic prescription patterns in patients with schizo phrenia.-a nationwide retrospective cohort study[J. Schizophr Res,2010,119(1 3) 145-152.
  • 3Dickinson D, Gold JM, Dickerson FB. Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabe- tes[J. Psychosomatics,2008,49(2) :12:3-131.
  • 4Prerona Mukherjee, Heather C,Whalley,et al. Lower effective connectivity between amygdala and parietal regions in response to fearful faces in schizophrenia[J]. Schizophrenia Research, 2012,134:118-124.
  • 5Joseph V,Shelley R, Chris J, et al. Memory functioning and negative symptoms as differential predictors of social problem solving skills in schizophrenia[-J-]. Schizophrenia Research, 2012,143 ;307-311.
  • 6P Gorwood, J Peuskens. Setting new tandards in schizophrenia outcomes: Symptomatic remission 3 years before versus after the andreasen criteria[J]. European Psychiatry, 2012,27 : 170- 175.
  • 7Gallhofer B, Bauer U, Lis S, et al. Cognitive dysfunction in schizophrenia : comparison of treatment with atypical antipsy- chotic agents and conventional neuroleptics[J]. Euro Neuropsy - hopharmacology, 1996,6 Suppl 2 : S13 - 20.
  • 8Madelia A,Lim R. Treatment of cognitive dysfunction in psy- chiatric disorders[J]. J Psyehiatr Pract,2004,10(1) :17-25.
  • 9Dasgupta A, Singh OP, Rout JK, et al. Insulin resistance and metabolic profile in antipsychotic native schizophrenia patients [J]. Prog Neuropsy- chopharmacol Biol Psychiatry, 2010,34 (7) :1 202-1 207.
  • 10Smith M, Hopkins D, Peveler RC, et al. First-v. second- generation antipsychotics and risk for diabetes in schizophreni- a: systematic review and meta-analysis[J]. Br J Psychiatry, 2008,192(6) :406-411.

引证文献9

二级引证文献52

中国实用神经疾病杂志
2012年 第24期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部